RT Conference Proceedings
T1 EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY.
A1 Calvo Gutierrez, J.
A1 Lopez-Medina, C.
A1 Abalos-Aguilera, M. C.
A1 Perez Jimenez, A. B.
A1 Ruiz-Vilchez, D.
A1 Pilar, F. U.
A1 Ortega Castro, R.
A1 Escudero Contreras, A.
A1 Collantes Estevez, E.
AB In the current situation of the SARS-CoV-2 pandemic, the Spanish Society of Rheumatology recommends vaccination of patients with chronic inflammatory diseases (CID) under treatment with biological DMARDs (bDMARDs). However, the data regarding the generation of protective antibody titers after mRNA vaccines in patients with CID is limited.
PB Bmj publishing group
SN 0003-4967
YR 2022
FD 2022-06-01
LK http://hdl.handle.net/10668/20109
UL http://hdl.handle.net/10668/20109
LA en
NO Gutierrez JC, López-Medina C, Ábalos-Aguilera MC, Jiménez ABP, Ruíz-Vilchez D, Pilar FU, et al. AB1149 EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-COV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):1691.2-1692.
DS RISalud
RD Apr 12, 2025